pre-miRNA Information
pre-miRNA hsa-mir-383   
Genomic Coordinates chr8: 14853438 - 14853510
Synonyms MIRN383, hsa-mir-383, MIR383
Description Homo sapiens miR-383 stem-loop
Comment None
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-383-5p
Sequence 7| AGAUCAGAAGGUGAUUGUGGCU |28
Evidence Experimental
Experiments Cloned
DRVs in miRNA
Mutant ID Mutant Position Mutant Source
COSN26994512 7 COSMIC
COSN30109318 22 COSMIC
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs112302475 1 dbSNP
rs756858316 1 dbSNP
rs757040124 3 dbSNP
rs1419085595 4 dbSNP
rs912771170 5 dbSNP
rs1190491141 6 dbSNP
rs986831934 7 dbSNP
rs1471946963 9 dbSNP
rs1237080909 10 dbSNP
rs757526216 11 dbSNP
rs1431645579 13 dbSNP
rs763747200 13 dbSNP
rs184836993 15 dbSNP
rs913343525 17 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol NRF1   
Synonyms ALPHA-PAL
Description nuclear respiratory factor 1
Transcript NM_001040110   
Other Transcripts NM_005011   
Expression
Putative miRNA Targets on NRF1
3'UTR of NRF1
(miRNA target sites are highlighted)
>NRF1|NM_001040110|3'UTR
   1 CATACAGCCATATTATGGCATCGTTTTCTAGTCTACTTCAAAATTTTTTACACGTTTGCAGAGGTGCAATCAAATGGAAT
  81 TAAGTCTCTCGACTTTGGAAGGAAAGTTTTGTTAACCTTTTTTTTTTTAAAAGGAAGAAAGCGGATTTTGGAATTGCATT
 161 TTTTAAAGCACCACTCTTGATTTTCTGGGATTGGTGAAGAAACTGCATTGTCAATTTCACTGTCCCAAAAAAGCCAAATT
 241 GTGGCAGGACTTCTTTCTGCGGAAATGTGTGTGTATACTTATGTGTGTGTATGTGTGAGTGTGAATATATGTATATGTGT
 321 ACATATGGACATACACATTTACATATATATAAAGTATATATATACATATATATATATATATATGTATGAAACCCGCATGG
 401 AATTATCTGTATGAAATCAAGGTGCGCTGTGGAAACAATAATTCACCCAGTTTAGTGGGTGGTAGGGTACGTGGCCAGAC
 481 ACAGTCACCCAGTTTTTGTTCATACCAGGGTCATGCGTTGAGCTACTGACAAACTCAGGCGGAGGTGACCATGCCCTTCA
 561 CCAAAGCTGCCTCCCAGTGGCCACACAGAACTCTCCCTGCTGGACTCACCTGAGGAAAGAGGCTCCAGCATGGGGTGGGT
 641 CAGAGATGTGCTTGCAAGGTCCAGGGACTGCGTGGTCTGCCAGCTGAGATGCTCCTCGGGCTGGCCCAGGTGCTGACCTT
 721 GCCACAGGCAGATGAATGTCTTGAAAGCTCCCGGGCCTCAGCCTCCCATCTCCTCTCCTTCCCAGGAATCCTTGATCTCA
 801 TGACTATTAAAATGTTGCTCTGGTTTTAAGGTCAGTCCTGAATTGCTCGTATATATGAACTGAAGGTAACCGAAGTATTA
 881 GGGGTTTGAGGAGTGCGTGCGTGTAAGTGTGCTTGTGTGTGTGCGTGCATGGTGGGGGAGAGGATGGGAAGGGGGCGGGG
 961 GCAGTGGAAGGGAAAGGAAGGAAAGAAAAATCGTCCTAGACCAGGATACACCCGTGGGAGCAATTTTCTCTACTGTCTGT
1041 AGCTTCACAGAGGAGGCGCTGGAATGAACAAGAAGAGACATCTGGTCTGTGGCCACAGCACCCTGAACGCCCCTGATCTT
1121 GTGTGATCTTGGAAGCTAAGCTTGGTTGGGCCCGGTCAGTACGCGGAAGGGAAGAAGGGACACCTGGCCATAGAAAACAG
1201 CTGAGGGTGTTTGCTGTGTTCCTGGATCAGGCCCTGCTTCAGAAGGGACTCCTGGAGGCCCATGTTCCTTGATGCAACCT
1281 CGTGGCCCAGGCCGGGAGCAGCTTGCCTCCTCAGAGGTGTTGACTATCTGGGTGTTCTTGGTAACCGTTAACTCTGTCTT
1361 TCTCAGCTGCAAGCCCTGAGTCTCCAGTAGCTGAATTCACCTGACTTTTCAACAGGCCAAATCTCTGAACCTTGAGTACA
1441 GGGACAGCTCCTCCTCCCTCCTCCCAGCTCTCCCCATGTGTGTGATGGTGTATTTAATGTGTTTTTTTAATGCGACATTA
1521 AAAGATTCTCCACGTCTTGCTCAACCTTTGAGAGAAGTTTCAGATTCTTGTATTTGCTTGTTTTATATAAAACTATCTAA
1601 TGTTCTTTATATGTTCTTTTCTGTACGTAATGGGGGGAGGGGAGGGAAATTTACATATAAATAGTCCTAGTTCTACAATT
1681 TGTTATTTTTTTAATTATTATTTTTTATCGTCATTGTGAAGTTGTCCAGGGACTTTAAAGTCCATGTTCCTTTGTGGTGA
1761 AATAACCTCCAAATAGTTTGAGAAGTTGCCAAGACGAAGAAAAAAGCAAAACCCCAGTAGCAGAGCATGGATTCTGTGTT
1841 GTTTCCCATTCTGTCTTTGACTGCCTCATTCAATAAATAGTTAAAAATGTGGCAACAGGAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' ucGGUGUUAGUGGAAGACUAGa 5'
            | | ||  : | ||||:|| 
Target 5' aaCAAGAAGAGACATCTGGTCt 3'
1067 - 1088 132.00 -10.60
2
miRNA  3' ucgGUGUUAGUGG----AAGACUAGa 5'
             ||||:|||||    ||:|| || 
Target 5' agaCACAGTCACCCAGTTTTTGTTCa 3'
477 - 502 129.00 -16.80
3
miRNA  3' ucGGUGUUAGUGGAAGACUAGa 5'
            || ::| |:||  |||||| 
Target 5' caCCCTGAACGCC-CCTGATCt 3'
1099 - 1119 127.00 -17.00
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN30474491 18 COSMIC
COSN31585029 47 COSMIC
COSN31559782 54 COSMIC
COSN17181620 55 COSMIC
COSN31563446 68 COSMIC
COSN30153501 78 COSMIC
COSN9828826 92 COSMIC
COSN20057663 129 COSMIC
COSN20070174 129 COSMIC
COSN20076159 130 COSMIC
COSN31536035 133 COSMIC
COSN30171341 166 COSMIC
COSN18719204 175 COSMIC
COSN31535844 260 COSMIC
COSN30538466 381 COSMIC
COSN2201225 484 COSMIC
COSN31533030 573 COSMIC
COSN9828827 611 COSMIC
COSN26638781 676 COSMIC
COSN30164328 760 COSMIC
COSN31530849 768 COSMIC
COSN26638782 831 COSMIC
COSN31538476 872 COSMIC
COSN31576039 937 COSMIC
COSN9922865 1287 COSMIC
COSN20091692 1294 COSMIC
COSN7959791 1338 COSMIC
COSN29354221 1443 COSMIC
COSN31529508 1514 COSMIC
COSN31608358 1627 COSMIC
COSN25781502 1629 COSMIC
COSN31602620 1789 COSMIC
COSN30173238 1800 COSMIC
COSN31521377 1820 COSMIC
COSN26564687 1864 COSMIC
rs11557288 1154 GWAS
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs561516450 2 dbSNP
rs1283849481 6 dbSNP
rs548630950 16 dbSNP
rs774071452 17 dbSNP
rs1216153912 18 dbSNP
rs1258629731 23 dbSNP
rs374795819 24 dbSNP
rs772239945 26 dbSNP
rs773271929 28 dbSNP
rs367693210 31 dbSNP
rs1327929816 42 dbSNP
rs760861466 47 dbSNP
rs770904055 51 dbSNP
rs769964528 52 dbSNP
rs1173344439 53 dbSNP
rs1053093976 54 dbSNP
rs45578637 55 dbSNP
rs1169908885 61 dbSNP
rs1158654503 70 dbSNP
rs997274572 75 dbSNP
rs1428709544 76 dbSNP
rs1030108137 90 dbSNP
rs576793370 91 dbSNP
rs953259407 92 dbSNP
rs1301130893 94 dbSNP
rs1007885936 109 dbSNP
rs1270309842 110 dbSNP
rs1181509628 112 dbSNP
rs1002170139 118 dbSNP
rs906525506 118 dbSNP
rs540622556 129 dbSNP
rs963338518 130 dbSNP
rs1260707826 134 dbSNP
rs1224887380 137 dbSNP
rs1324163175 139 dbSNP
rs971744647 143 dbSNP
rs374338238 144 dbSNP
rs959765649 161 dbSNP
rs992603008 162 dbSNP
rs1337342323 171 dbSNP
rs916062442 174 dbSNP
rs1331076840 175 dbSNP
rs948949694 205 dbSNP
rs1447811428 209 dbSNP
rs1405716374 213 dbSNP
rs574192790 221 dbSNP
rs926229148 222 dbSNP
rs1226228016 225 dbSNP
rs1021112306 227 dbSNP
rs879009425 229 dbSNP
rs1468881771 242 dbSNP
rs1287267415 251 dbSNP
rs1234979281 258 dbSNP
rs1323779252 261 dbSNP
rs141846179 262 dbSNP
rs1460594118 263 dbSNP
rs902286388 266 dbSNP
rs934633031 270 dbSNP
rs768595292 274 dbSNP
rs1204988858 280 dbSNP
rs1323674619 282 dbSNP
rs997944283 282 dbSNP
rs563127571 283 dbSNP
rs1352502034 286 dbSNP
rs1279921116 288 dbSNP
rs1245050376 298 dbSNP
rs1335018202 299 dbSNP
rs1482892926 299 dbSNP
rs953723415 302 dbSNP
rs1359844625 316 dbSNP
rs530584628 317 dbSNP
rs1399474364 321 dbSNP
rs747147881 334 dbSNP
rs1159612835 335 dbSNP
rs1471457421 343 dbSNP
rs1382968838 346 dbSNP
rs1185084302 352 dbSNP
rs1241029648 355 dbSNP
rs1483262651 355 dbSNP
rs1016826243 356 dbSNP
rs1448650020 360 dbSNP
rs1430289434 361 dbSNP
rs1221420469 362 dbSNP
rs1357050141 364 dbSNP
rs962573896 364 dbSNP
rs10580617 366 dbSNP
rs114698645 366 dbSNP
rs1248463170 366 dbSNP
rs1347439761 366 dbSNP
rs138036238 366 dbSNP
rs1416015600 366 dbSNP
rs143325914 366 dbSNP
rs143579598 366 dbSNP
rs398006268 366 dbSNP
rs55725001 366 dbSNP
rs770671807 366 dbSNP
rs149250308 370 dbSNP
rs1424377646 371 dbSNP
rs1049837370 374 dbSNP
rs1174122388 376 dbSNP
rs1165024893 377 dbSNP
rs973001000 378 dbSNP
rs202117034 381 dbSNP
rs1184237016 383 dbSNP
rs1476132577 389 dbSNP
rs568624831 395 dbSNP
rs202032293 396 dbSNP
rs1007398527 413 dbSNP
rs1016553312 415 dbSNP
rs899097328 416 dbSNP
rs1322536841 421 dbSNP
rs564181656 426 dbSNP
rs1025968790 427 dbSNP
rs1364206459 428 dbSNP
rs1284294008 437 dbSNP
rs1055099704 448 dbSNP
rs959735060 456 dbSNP
rs1343952752 458 dbSNP
rs1305333301 460 dbSNP
rs992570673 460 dbSNP
rs1298561465 463 dbSNP
rs532549069 466 dbSNP
rs1353529025 471 dbSNP
rs114187848 472 dbSNP
rs970592593 474 dbSNP
rs1228093269 475 dbSNP
rs1276743769 483 dbSNP
rs1042990655 485 dbSNP
rs1459985976 499 dbSNP
rs1271031739 502 dbSNP
rs1191528955 514 dbSNP
rs1332833495 517 dbSNP
rs902674317 518 dbSNP
rs1232474996 528 dbSNP
rs1202721035 531 dbSNP
rs1320017563 540 dbSNP
rs566222433 541 dbSNP
rs536720503 542 dbSNP
rs1304103208 543 dbSNP
rs1387669879 544 dbSNP
rs1269313830 546 dbSNP
rs1373086322 547 dbSNP
rs1296037074 557 dbSNP
rs1006525000 561 dbSNP
rs1400667658 562 dbSNP
rs1016536378 572 dbSNP
rs1189629933 579 dbSNP
rs962641329 581 dbSNP
rs972667448 587 dbSNP
rs1025946879 589 dbSNP
rs1248165147 595 dbSNP
rs926169403 595 dbSNP
rs1429153641 596 dbSNP
rs971256411 600 dbSNP
rs981656860 601 dbSNP
rs1388907955 615 dbSNP
rs928044829 624 dbSNP
rs934899344 626 dbSNP
rs989045746 630 dbSNP
rs1258237221 632 dbSNP
rs1234623704 634 dbSNP
rs1316635356 635 dbSNP
rs548831803 638 dbSNP
rs1305306993 639 dbSNP
rs1242847262 645 dbSNP
rs752400745 646 dbSNP
rs1448189780 653 dbSNP
rs1304142956 655 dbSNP
rs878935072 670 dbSNP
rs1377150999 671 dbSNP
rs1367770053 673 dbSNP
rs922600751 675 dbSNP
rs934026632 676 dbSNP
rs938061976 680 dbSNP
rs1438205163 684 dbSNP
rs990845510 685 dbSNP
rs1362058749 689 dbSNP
rs1049763333 692 dbSNP
rs1366442124 693 dbSNP
rs915245046 698 dbSNP
rs1440125906 704 dbSNP
rs11760927 710 dbSNP
rs1382336950 711 dbSNP
rs1381109110 714 dbSNP
rs1183249377 722 dbSNP
rs1442800098 724 dbSNP
rs946994895 728 dbSNP
rs11557287 731 dbSNP
rs868103225 734 dbSNP
rs1259537972 753 dbSNP
rs1037530003 754 dbSNP
rs899018571 758 dbSNP
rs1292238922 760 dbSNP
rs537613397 761 dbSNP
rs35049738 762 dbSNP
rs1313854746 764 dbSNP
rs1323245056 765 dbSNP
rs1026270204 785 dbSNP
rs759832672 803 dbSNP
rs559205235 807 dbSNP
rs780042158 821 dbSNP
rs769999987 826 dbSNP
rs577424298 840 dbSNP
rs534662322 841 dbSNP
rs1006593028 843 dbSNP
rs1382664490 845 dbSNP
rs1246400692 849 dbSNP
rs552673839 850 dbSNP
rs1420033989 853 dbSNP
rs574228361 868 dbSNP
rs1190678459 871 dbSNP
rs541541682 872 dbSNP
rs1038034941 873 dbSNP
rs1246252509 893 dbSNP
rs1013931195 897 dbSNP
rs1428032883 897 dbSNP
rs563018892 898 dbSNP
rs969846246 901 dbSNP
rs753676350 902 dbSNP
rs1358011162 904 dbSNP
rs1365926271 904 dbSNP
rs1265713665 918 dbSNP
rs1033162520 925 dbSNP
rs956246467 926 dbSNP
rs575102817 935 dbSNP
rs1002736575 937 dbSNP
rs1406929331 938 dbSNP
rs1393112913 939 dbSNP
rs1164077393 944 dbSNP
rs1403997776 946 dbSNP
rs763483693 952 dbSNP
rs1034168201 955 dbSNP
rs191089608 957 dbSNP
rs764762927 958 dbSNP
rs564448361 960 dbSNP
rs146285024 962 dbSNP
rs1267551532 964 dbSNP
rs1194887380 965 dbSNP
rs1336804265 966 dbSNP
rs1321985800 978 dbSNP
rs1218775350 985 dbSNP
rs147977173 993 dbSNP
rs941438241 994 dbSNP
rs1434324362 995 dbSNP
rs1038901690 996 dbSNP
rs1331490451 1002 dbSNP
rs920419934 1006 dbSNP
rs1391040515 1009 dbSNP
rs924230737 1010 dbSNP
rs934224312 1011 dbSNP
rs929132447 1012 dbSNP
rs80150480 1014 dbSNP
rs575258120 1015 dbSNP
rs1378580749 1027 dbSNP
rs530078684 1035 dbSNP
rs1181628086 1037 dbSNP
rs1435706958 1038 dbSNP
rs1239675958 1047 dbSNP
rs1198694117 1049 dbSNP
rs1381226814 1053 dbSNP
rs1261118933 1055 dbSNP
rs895754249 1057 dbSNP
rs942836660 1058 dbSNP
rs1038087340 1059 dbSNP
rs1013899438 1070 dbSNP
rs1317811265 1070 dbSNP
rs898224718 1070 dbSNP
rs1333663619 1071 dbSNP
rs993860486 1071 dbSNP
rs1044053584 1080 dbSNP
rs879907826 1081 dbSNP
rs548721114 1095 dbSNP
rs907139790 1105 dbSNP
rs1403616941 1113 dbSNP
rs1003202350 1129 dbSNP
rs57720104 1131 dbSNP
rs958537639 1144 dbSNP
rs745374409 1147 dbSNP
rs1239763793 1149 dbSNP
rs11557288 1154 dbSNP
rs1211698509 1155 dbSNP
rs1033207402 1163 dbSNP
rs956171883 1164 dbSNP
rs1010360285 1165 dbSNP
rs141644782 1166 dbSNP
rs955611201 1174 dbSNP
rs571153290 1191 dbSNP
rs1307157175 1192 dbSNP
rs1196782245 1204 dbSNP
rs955683238 1217 dbSNP
rs987020591 1223 dbSNP
rs986142730 1231 dbSNP
rs80344027 1232 dbSNP
rs1336783450 1236 dbSNP
rs1360894688 1245 dbSNP
rs1038471118 1252 dbSNP
rs1423598876 1254 dbSNP
rs182642976 1255 dbSNP
rs919713159 1258 dbSNP
rs1009876053 1267 dbSNP
rs750008492 1274 dbSNP
rs1472863188 1276 dbSNP
rs1241407675 1277 dbSNP
rs1191446221 1278 dbSNP
rs1489110695 1282 dbSNP
rs755814438 1283 dbSNP
rs974151690 1284 dbSNP
rs537483999 1294 dbSNP
rs929101417 1295 dbSNP
rs1373735607 1297 dbSNP
rs768737866 1299 dbSNP
rs1230484216 1304 dbSNP
rs1270063540 1309 dbSNP
rs1398704576 1314 dbSNP
rs1055724747 1318 dbSNP
rs13241028 1322 dbSNP
rs556649681 1323 dbSNP
rs949978572 1327 dbSNP
rs1166514508 1328 dbSNP
rs1044745938 1335 dbSNP
rs530886427 1336 dbSNP
rs754907844 1347 dbSNP
rs1167997995 1348 dbSNP
rs1209948295 1352 dbSNP
rs1000009633 1353 dbSNP
rs1054091633 1357 dbSNP
rs1198378553 1365 dbSNP
rs778869257 1366 dbSNP
rs546026704 1370 dbSNP
rs1031050996 1371 dbSNP
rs1224060186 1382 dbSNP
rs955558308 1389 dbSNP
rs1257504468 1393 dbSNP
rs1180444796 1398 dbSNP
rs891563329 1402 dbSNP
rs1279432940 1405 dbSNP
rs557645333 1408 dbSNP
rs1223240329 1417 dbSNP
rs986739137 1424 dbSNP
rs1436743443 1440 dbSNP
rs1353618840 1443 dbSNP
rs1328659144 1457 dbSNP
rs1010330499 1458 dbSNP
rs1409362818 1459 dbSNP
rs1466767367 1467 dbSNP
rs1472060232 1469 dbSNP
rs1424198862 1470 dbSNP
rs1175640162 1471 dbSNP
rs1431172066 1474 dbSNP
rs542082787 1476 dbSNP
rs1029768801 1477 dbSNP
rs1403651128 1478 dbSNP
rs1237858091 1483 dbSNP
rs1196795575 1492 dbSNP
rs1412694890 1498 dbSNP
rs974232856 1502 dbSNP
rs1233176582 1505 dbSNP
rs867236745 1512 dbSNP
rs1311025788 1514 dbSNP
rs117268498 1515 dbSNP
rs1220224425 1520 dbSNP
rs929778051 1522 dbSNP
rs757287521 1529 dbSNP
rs1306667879 1534 dbSNP
rs540169569 1535 dbSNP
rs928366025 1545 dbSNP
rs938347962 1567 dbSNP
rs572268349 1568 dbSNP
rs1305948893 1572 dbSNP
rs1360885622 1576 dbSNP
rs962703786 1579 dbSNP
rs1224292608 1586 dbSNP
rs1379876884 1593 dbSNP
rs1418329098 1593 dbSNP
rs781354757 1597 dbSNP
rs111364957 1600 dbSNP
rs1238871913 1600 dbSNP
rs1042934650 1606 dbSNP
rs1342913165 1610 dbSNP
rs1482549614 1611 dbSNP
rs1258329416 1612 dbSNP
rs1211211579 1618 dbSNP
rs1025706912 1624 dbSNP
rs746016357 1627 dbSNP
rs998660461 1628 dbSNP
rs1031521617 1630 dbSNP
rs1203540427 1632 dbSNP
rs1311379340 1635 dbSNP
rs1393845432 1636 dbSNP
rs1381219371 1637 dbSNP
rs891180453 1655 dbSNP
rs992266743 1656 dbSNP
rs1358406414 1660 dbSNP
rs1157011544 1663 dbSNP
rs917084521 1666 dbSNP
rs1421739417 1677 dbSNP
rs1381203069 1680 dbSNP
rs1186890064 1682 dbSNP
rs1008210052 1686 dbSNP
rs1258809125 1691 dbSNP
rs1482533561 1693 dbSNP
rs751010509 1694 dbSNP
rs1488127829 1695 dbSNP
rs1284312610 1696 dbSNP
rs1219329176 1702 dbSNP
rs561935131 1708 dbSNP
rs139498398 1710 dbSNP
rs144317536 1711 dbSNP
rs1171447076 1727 dbSNP
rs935656062 1728 dbSNP
rs1299785523 1731 dbSNP
rs1431536137 1734 dbSNP
rs546301861 1737 dbSNP
rs951635705 1750 dbSNP
rs982949636 1755 dbSNP
rs1369643956 1758 dbSNP
rs928387843 1774 dbSNP
rs938400130 1777 dbSNP
rs1370272568 1779 dbSNP
rs1165649428 1782 dbSNP
rs1477771082 1783 dbSNP
rs1329542445 1797 dbSNP
rs1196264574 1798 dbSNP
rs1488840848 1800 dbSNP
rs1266172400 1805 dbSNP
rs1207716099 1826 dbSNP
rs1435899678 1828 dbSNP
rs1489137187 1836 dbSNP
rs991177414 1855 dbSNP
rs915578296 1863 dbSNP
rs1226767210 1868 dbSNP
rs1274379350 1869 dbSNP
rs1218960727 1872 dbSNP
rs947001798 1873 dbSNP
rs1043369128 1874 dbSNP
rs767446620 1875 dbSNP
rs750296322 1876 dbSNP
rs1211976967 1878 dbSNP
rs1326640528 1882 dbSNP
rs564106620 1883 dbSNP
rs1269068773 1884 dbSNP
rs1054061030 1887 dbSNP
rs891487944 1890 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM545213. RNA binding protein: AGO2. Condition:Control ...

- Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' ucGGUGUUAGUGGAAGACUAGa 5'
            || ::| |:||  |||||| 
Target 5' caCCCUGAACGCC-CCUGAUC- 3'
1 - 20
Article - Hafner M; Landthaler M; Burger L; Khorshid et al.
- Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
Experimental Support 2 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions hESCs (WA-09)
Disease 4899.0
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... "PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine ...

- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development.

Article - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al.
- Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
Experimental Support 3 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions C8166
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3 ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' ucGGUGUUAGUGGAAGACUAGa 5'
            || ::| |:||  |||||| 
Target 5' caCCCUGAACGCC-CCUGAUCu 3'
1 - 21
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
Experimental Support 4 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HCT116
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in ERX177630. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_8 PAR-CLIP data was present in ERX177599. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_1 PAR-CLIP data was present in ERX177603. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_5 PAR-CLIP data was present in ERX177607. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_9 PAR-CLIP data was present in ERX177611. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_1 PAR-CLIP data was present in ERX177619. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_9 PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1 PAR-CLIP data was present in ERX177631. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_9 PAR-CLIP data was present in ERX177618. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_8 PAR-CLIP data was present in ERX177615. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_5 PAR-CLIP data was present in ERX177627. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_5 ...

- Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research.

Article - Krell J; Stebbing J; Carissimi C; Dabrowska et al.
- Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
CLIP-seq Support 1 for dataset GSM545213
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / Control
Location of target site ENST00000393230.2 | 3UTR | CACCCUGAACGCCCCUGAUC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 20371350 / GSE21578
CLIP-seq Viewer Link
CLIP-seq Support 2 for dataset SRR359787
Method / RBP PAR-CLIP / AGO2
Cell line / Condition hESCs (WA-09) / 4-thiouridine, RNase T1
Location of target site ENST00000393230.2 | 3UTR | GUCUGUGGCCACAGCACCCUGAACGCCCCUGAUCUUGUGUGAUCUUGGAAGCUAAGCUUGGUUGGGCC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 22012620 / SRX103431
CLIP-seq Viewer Link
CLIP-seq Support 3 for dataset GSM1462572
Method / RBP PAR-CLIP / AGO2
Cell line / Condition C8166 / C8166 NL4-3
Location of target site ENST00000393230.2 | 3UTR | CACCCUGAACGCCCCUGAUCU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
HNSC 0.556 0.04 0.455 0.08 11 Click to see details
BRCA 0.246 0.1 0.229 0.11 30 Click to see details
STAD 0.289 0.12 0.296 0.12 18 Click to see details
LIHC -0.226 0.12 -0.235 0.11 28 Click to see details
PAAD -0.85 0.18 -1.000 0.5 3 Click to see details
LUSC -0.516 0.19 -0.600 0.14 5 Click to see details
PRAD 0.101 0.26 0.141 0.18 44 Click to see details
CHOL -0.114 0.41 -0.143 0.39 6 Click to see details
BLCA -0.037 0.46 -0.127 0.35 11 Click to see details
UCEC 0.067 0.47 0.200 0.4 4 Click to see details
UCEC 0.067 0.47 0.200 0.4 4 Click to see details
UCEC 0.067 0.47 0.200 0.4 4 Click to see details
UCEC 0.067 0.47 0.200 0.4 4 Click to see details
UCEC 0.067 0.47 0.200 0.4 4 Click to see details
UCEC 0.067 0.47 0.200 0.4 4 Click to see details
UCEC 0.067 0.47 0.200 0.4 4 Click to see details
UCEC 0.067 0.47 0.200 0.4 4 Click to see details
96 hsa-miR-383-5p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT004443 VEGFA vascular endothelial growth factor A 5 2
MIRT006137 DIO1 iodothyronine deiodinase 1 3 1
MIRT006535 IRF1 interferon regulatory factor 1 3 1
MIRT007246 IGF1R insulin like growth factor 1 receptor 1 1
MIRT007305 PRDX3 peroxiredoxin 3 1 1
MIRT054359 CCND1 cyclin D1 4 2
MIRT057087 DDIT4 DNA damage inducible transcript 4 2 2
MIRT086536 HSPE1-MOB4 HSPE1-MOB4 readthrough 2 2
MIRT086544 MOB4 MOB family member 4, phocein 2 2
MIRT438194 PPP1R10 protein phosphatase 1 regulatory subunit 10 3 1
MIRT448282 ZMYM2 zinc finger MYM-type containing 2 2 2
MIRT451601 TRPM7 transient receptor potential cation channel subfamily M member 7 2 2
MIRT453387 RHD Rh blood group D antigen 2 2
MIRT458521 C5orf22 chromosome 5 open reading frame 22 2 2
MIRT459720 SGK494 uncharacterized serine/threonine-protein kinase SgK494 2 2
MIRT461491 KIAA1009 centrosomal protein 162 1 1
MIRT463261 ZIC5 Zic family member 5 2 2
MIRT464237 VCP valosin containing protein 2 2
MIRT465320 TRAF5 TNF receptor associated factor 5 2 2
MIRT465774 TMOD3 tropomodulin 3 2 2
MIRT467879 SLC22A23 solute carrier family 22 member 23 2 2
MIRT469636 RAD21 RAD21 cohesin complex component 2 6
MIRT472041 NPAT nuclear protein, coactivator of histone transcription 2 2
MIRT476568 GABARAPL1 GABA type A receptor associated protein like 1 2 2
MIRT478586 CTDSPL2 CTD small phosphatase like 2 2 2
MIRT478870 CREBRF CREB3 regulatory factor 2 2
MIRT482202 AHR aryl hydrocarbon receptor 2 2
MIRT484237 IER2 immediate early response 2 2 2
MIRT487480 NRF1 nuclear respiratory factor 1 2 6
MIRT493746 GRAP2 GRB2-related adaptor protein 2 2 2
MIRT496836 ZNF460 zinc finger protein 460 2 2
MIRT497234 APOL2 apolipoprotein L2 2 2
MIRT499424 PLCG2 phospholipase C gamma 2 2 9
MIRT500598 UBN2 ubinuclein 2 2 10
MIRT502859 CHEK2 checkpoint kinase 2 2 6
MIRT507727 CLIC4 chloride intracellular channel 4 2 4
MIRT510509 YOD1 YOD1 deubiquitinase 2 6
MIRT511901 FNBP1L formin binding protein 1 like 2 6
MIRT514393 CLUAP1 clusterin associated protein 1 2 2
MIRT520180 WBP2 WW domain binding protein 2 2 4
MIRT531214 PLA2G4D phospholipase A2 group IVD 2 2
MIRT532846 ZNF699 zinc finger protein 699 2 2
MIRT533461 TRIM71 tripartite motif containing 71 2 2
MIRT539263 ANKRD44 ankyrin repeat domain 44 2 2
MIRT539380 ADSS adenylosuccinate synthase 2 6
MIRT548129 GAS1 growth arrest specific 1 2 2
MIRT550662 ZFP37 ZFP37 zinc finger protein 2 2
MIRT551499 CENPN centromere protein N 2 2
MIRT553778 TAF13 TATA-box binding protein associated factor 13 2 2
MIRT554376 SFPQ splicing factor proline and glutamine rich 2 2
MIRT555821 PCDH11Y protocadherin 11 Y-linked 2 4
MIRT557558 GOSR1 golgi SNAP receptor complex member 1 2 2
MIRT557694 GATA6 GATA binding protein 6 2 2
MIRT561383 TWF1 twinfilin actin binding protein 1 2 2
MIRT561414 TSN translin 2 2
MIRT561867 MSH6 mutS homolog 6 2 2
MIRT567383 GTPBP3 GTP binding protein 3, mitochondrial 2 2
MIRT569272 PCDH11X protocadherin 11 X-linked 2 2
MIRT569556 UNC119B unc-119 lipid binding chaperone B 2 2
MIRT569760 RIMBP3C RIMS binding protein 3C 2 5
MIRT573387 GGA2 golgi associated, gamma adaptin ear containing, ARF binding protein 2 2 2
MIRT573456 RPL41 ribosomal protein L41 2 2
MIRT573968 DDX21 DExD-box helicase 21 2 2
MIRT574163 ATG10 autophagy related 10 2 2
MIRT574659 KLHL15 kelch like family member 15 2 2
MIRT574907 Plcg2 phospholipase C, gamma 2 2 6
MIRT607496 HEBP2 heme binding protein 2 2 2
MIRT612840 KCNJ12 potassium voltage-gated channel subfamily J member 12 2 4
MIRT613962 TMEM59 transmembrane protein 59 2 2
MIRT621125 PCNXL2 pecanex homolog 2 2 2
MIRT625216 SH3TC2 SH3 domain and tetratricopeptide repeats 2 2 2
MIRT643337 MICA MHC class I polypeptide-related sequence A 2 2
MIRT646342 CLIC6 chloride intracellular channel 6 2 2
MIRT647361 WDR5B WD repeat domain 5B 2 2
MIRT650308 SLC35E2 solute carrier family 35 member E2 2 2
MIRT651372 ZBTB21 zinc finger and BTB domain containing 21 2 2
MIRT655301 PEAR1 platelet endothelial aggregation receptor 1 2 2
MIRT681918 SLC11A2 solute carrier family 11 member 2 2 2
MIRT684165 ALDH1B1 aldehyde dehydrogenase 1 family member B1 2 2
MIRT688053 GLUL glutamate-ammonia ligase 2 2
MIRT690210 C5orf45 MRN complex interacting protein 2 2
MIRT691024 CRTC3 CREB regulated transcription coactivator 3 2 2
MIRT697699 WAC WW domain containing adaptor with coiled-coil 2 2
MIRT698201 TMEM30A transmembrane protein 30A 2 2
MIRT698857 SRSF2 serine and arginine rich splicing factor 2 2 2
MIRT702292 LDHA lactate dehydrogenase A 4 2
MIRT703341 GDPD5 glycerophosphodiester phosphodiesterase domain containing 5 2 2
MIRT704082 DYRK2 dual specificity tyrosine phosphorylation regulated kinase 2 2 2
MIRT713729 SUCO SUN domain containing ossification factor 2 2
MIRT719487 RBM27 RNA binding motif protein 27 2 2
MIRT722080 SMC2 structural maintenance of chromosomes 2 2 2
MIRT724102 TMEM199 transmembrane protein 199 2 2
MIRT725124 SYNRG synergin gamma 2 2
MIRT725601 CAPN6 calpain 6 2 2
MIRT737186 RBM3 RNA binding motif (RNP1, RRM) protein 3 4 0
MIRT755379 NOS3 nitric oxide synthase 3 3 1
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-383 Glucose NULL 5793 Quantitative real-time PCR endothelial cells 24394957 2014 down-regulated
miR-383 Vorinostat (SAHA) approved 5311 Microarray A549 human non-small cell lung cancer cells 19513533 2009 up-regulated
miR-383 5-Fluorouracil approved 3385 Microarray CNE cells 22614822 2012 up-regulated
miR-383 Doxorubicin approved 31703 Microarray heart 22859947 2012 up-regulated
miR-383 Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) NULL 8490 Microarray mouse brain 19270793 2009 down-regulated
miR-383 Tert-butyl hydroperoxide (t-BHP) NULL 6410 Microarray mouse auditory cells 20510889 2010 down-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-miR-383-5p Vincristine 5978 approved resistant High Lymphoblastic Leukemia tissue
hsa-miR-383-5p Daunorubicin 30323 NSC82151 approved resistant High Lymphoblastic Leukemia tissue
hsa-miR-383-5p Prednisolone 5755 NSC9120 approved resistant High Lymphoblastic Leukemia tissue
hsa-miR-383-5p L-Asparaginase resistant High Lymphoblastic Leukemia tissue
hsa-miR-383-5p Cisplatin 5460033 NSC119875 approved resistant High Germ Cell Tumor cell line (NTERA-2)
hsa-miR-383-5p Oxaliplatin 6857599 NSC266046 approved sensitive High Colorectal Cancer cell line (RKO)
hsa-miR-383-5p Oxaliplatin 6857599 NSC266046 approved resistant High Colorectal Cancer cell line (HT-29)
hsa-miR-383-5p Cisplatin 5460033 NSC119875 approved sensitive High Ovarian Cancer cell line (SKOV3)
hsa-miR-383-5p Docetaxel 148124 NSC628503 approved sensitive High Prostate Cancer cell line (PC-3)
hsa-miR-383-5p Cetuximab sensitive High Colon Cancer cell line
hsa-miR-383-5p Paclitaxel 36314 NSC125973 approved sensitive Low Ovarian Cancer cell line (OVCAR3, A2780)
hsa-miR-383-5p Doxorubicin 31703 NSC123127 approved sensitive Low Hepatocellular Carcinoma cell line (BT-474, SKBR3)
hsa-miR-383-5p Cetuximab + Folfox(Fluorouracil + Leucovorin + Oxaliplatin) resistant High Metastatic Colorectal Cancer tissue
hsa-miR-383-5p Gemcitabine 60750 NSC613327 approved sensitive Low Pancreatic Ductal Adenocarcinoma tissue
hsa-miR-383-5p Fluorouracil 3385 NSC19893 approved sensitive Low Gastric Cancer cell line (AGS)
hsa-miR-383-5p Oxaliplatin 6857599 NSC266046 approved resistant Low Hepatocellular Carcinoma cell line (Hep3B, Huh-7)
hsa-miR-383-5p Cisplatin 5460033 NSC119875 approved sensitive Low Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-383-5p Gefitinib 123631 NSC715055 approved resistant cell line (HCC827)
hsa-miR-383-5p Gefitinib 123631 NSC715055 approved sensitive cell line (PC9)
hsa-miR-383-5p Osimertinib 71496458 NSC779217 approved sensitive cell line (PC9)
hsa-miR-383-5p Cisplatin 5460033 NSC119875 approved sensitive cell line
hsa-miR-383-5p Cisplatin 5460033 NSC119875 approved resistant cell line (A549)
hsa-miR-383-5p Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-miR-383-5p Sunitinib 5329102 NSC750690 approved resistant tissue (CardA)
hsa-miR-383-5p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-383-5p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-383-5p Cisplatin 5460033 NSC119875 approved resistant cell line (A2780)
hsa-miR-383-5p Cetuximab resistant tissue (colorectal carcinoma)

Error report submission